Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Occlusive carotid, aortic, renal, mesenteric, and peripheral atherosclerotic disease".)
International
●Global vascular guidelines (GVG): Clinical practice guidelines on the management of chronic limb-threatening ischemia (2019)
●International Working Group on the Diabetic Foot (IWGDF): Guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes (2019)
Canada
●Canadian Cardiovascular Society (CCS): Guidelines for peripheral arterial disease (2022)
●Thrombosis Canada: Clinical guide on peripheral arterial disease (2021)
●Choosing Wisely Canada: Don't perform percutaneous interventions or bypass surgery as first line therapy in patients with asymptomatic peripheral arterial disease (PAD) and in most patients with claudication (2019)
●Choosing Wisely Canada: Don't perform stress cardiac imaging or advanced non-invasive imaging in the initial evaluation of patients without cardiac symptoms unless high-risk markers are present (2017)
●Society of Interventional Radiology (SIR) and Canadian Interventional Radiology Association (CIRA): Position statement on noninvasive imaging of peripheral arterial disease (2016)
United States
●American College of Radiology (ACR): ACR Appropriateness Criteria on lower extremity arterial claudication – Imaging assessment for revascularization (2022)
●American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine (ACC/AHA/SCAI/SIR/SVM): 2018 appropriate use criteria for peripheral artery intervention (published 2019)
●AHA: A science advisory implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease (2019)
●AHA: A scientific statement on optimal exercise programs for patients with peripheral artery disease (2018)
●SCAI: Consensus guidelines for device selection in femoral-popliteal arterial interventions (2018)
●Society for Vascular Surgery (SVS): Practice guidelines on follow-up after vascular surgery arterial procedures (2018)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on cardiovascular disease risk – Screening with electrocardiography (2018)
●USPSTF: Final recommendation statement on peripheral artery disease and cardiovascular disease – Screening and risk assessment with the ankle-brachial index (2018)
●ACR: ACR Appropriateness Criteria on lower extremity arterial revascularization-post-therapy imaging (2017)
●AHA/ACC: 2016 guideline on the management of patients with lower extremity peripheral artery disease (published 2017)
●Society of Interventional Radiology (SIR) and Canadian Interventional Radiology Association (CIRA): Position statement on noninvasive imaging of peripheral arterial disease (2016)
●SVS: Practice guidelines for atherosclerotic occlusive disease of the lower extremities – Management of asymptomatic disease and claudication (2015)
●American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines: on antithrombotic therapy and prevention of thrombosis, 9th edition (2012)
Europe
●European Society for Vascular Surgery (ESVS): Clinical practice guidelines on the management of acute limb ischaemia (2020)
●European Society of Cardiology (ESC) and ESVS: 2017 guidelines on the diagnosis and treatment of peripheral arterial diseases (published 2018)
United Kingdom
●Joint British Societies for the prevention of cardiovascular disease (JBS3): Peripheral arterial disease recommendations
●National Institute for Health and Care Excellence (NICE): Guideline on peripheral arterial disease – Diagnosis and management (2020)
●NICE: Clinical guideline on peripheral arterial disease – Diagnosis and management (2012, updated 2018)
●JBS3: Consensus recommendations for the prevention of cardiovascular disease (2014)
●NICE: Quality standard on peripheral arterial disease (2014)
Australia–New Zealand
●Choosing Wisely Australia: Don't screen asymptomatic, low-risk patients (<10% absolute 5-year CV risk) using ECG, stress test, coronary artery calcium score, or carotid artery ultrasound (2015)
